The Health Influences of Puberty (HIP) Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT01775813
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 104 participants
- Sponsor
- Registry
-
NCT01775813
-
- Other papers using this trial's data
- Adipose Depot Changes and Associated Metabolic Risk in the Longitudinal Health Influences of Puberty Study
- Two-Year Treatment With Metformin During Puberty Does Not Preserve β-Cell Function in Youth With Obesity
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01775813. Randomized; quadruple masking; primary purpose prevention. Start 2011-06 (actual); primary completion 2018-05-31 (actual). Results posted on 2022-02-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Health Influences of Puberty (HIP) Study
- Acronym
- HIP
- Condition
- Obesity
- Condition
- Insulin Resistance
- Condition
- Gonadal Dysfunction
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Colorado, Denver
- Collaborator
- American Diabetes Association
- Collaborator
- National Institutes of Health (NIH)
- Collaborator
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Collaborator
- Children's Hospital Colorado
Record details
- Record id
cardio:ct-nct01775813- Content hash
a998f4c50ec098578cfd44753c7b2a11cdce732e08a0324a6a09e832a8415ac2